KEN TAKANASHI Insider Profile
4 Followers
KEN TAKANASHI, Director at Wave Life Sciences, holds 9.63M shares in Wave Life Sciences (Ticker: WVE), holds 24.85M shares in Satsuma Pharmaceuticals (Ticker: STSA).
KEN TAKANASHI has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Director
Roles that KEN TAKANASHI holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by KEN TAKANASHI
KEN TAKANASHI's Trading History
Wave Life Sciences
Mar 26, 2026
Director
Uninformative Buy
―
$69.15M
Satsuma Pharmaceuticals
Jun 08, 2023
―
Uninformative Buy
20.07M
$27.33M
List of latest transactions for each holding click on a transaction to see KEN TAKANASHI's performance on stock
You May Also Like
KEN TAKANASHI insider profile FAQ
What is the percentage of profitable transactions made by KEN TAKANASHI?
The percentage of profitable transactions made by KEN TAKANASHI is ―.
What is the average return per transaction made by KEN TAKANASHI?
The average return per transaction made by KEN TAKANASHI is ―.
What stocks does KEN TAKANASHI hold?
KEN TAKANASHI holds: WVE, STSA stocks.
What was KEN TAKANASHI’s latest transaction?
KEN TAKANASHI latest transaction was an Uninformative Buy of ―.
What was KEN TAKANASHI's most profitable transaction?
KEN TAKANASHI’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is KEN TAKANASHI's role in Wave Life Sciences?
KEN TAKANASHI's role in Wave Life Sciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.